NBIS vs. NVO
NBIS (Nebius Group N.V.) and NVO (Novo Nordisk A/S) are both stocks. NBIS operates in Internet Content & Information (Communication Services), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past year, NBIS returned 314.21% vs -20.39% for NVO. At a 0.14 correlation, their price movements are largely independent.
Performance
NBIS vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NBIS achieves a 159.15% return, which is significantly higher than NVO's 0.44% return.
NBIS
- 1D
- 18.78%
- 1M
- -24.34%
- 6M
- 118.47%
- YTD
- 159.15%
- 1Y
- 314.21%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 301.22%
NVO
- 1D
- -0.46%
- 1M
- 14.33%
- 6M
- -15.78%
- YTD
- 0.44%
- 1Y
- -20.39%
- 3Y*
- -13.64%
- 5Y*
- 4.47%
- 10Y*
- 8.13%
- ALL TIME*
- 14.50%
NBIS vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
NBIS Nebius Group N.V. | 159.15% | 202.18% | 46.25% |
NVO Novo Nordisk A/S | 0.44% | -39.22% | -27.24% |
Correlation
The correlation between NBIS and NVO is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Oct 18, 2024 | 0.14 |
Fundamentals
NBIS:
$52.06B
NVO:
$219.43B
NBIS:
$3.08
NVO:
DKK 27.42
NBIS:
70.35
NVO:
11.79
NBIS:
24.17
NVO:
0.51
NBIS:
67.03
NVO:
4.39
NBIS:
9.26
NVO:
7.08
NBIS:
$877.90M
NVO:
DKK 327.80B
NBIS:
$420.60M
NVO:
DKK 268.30B
NBIS:
-$52.78M
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NBIS vs. NVO — Risk / Return Rank
NBIS
NVO
NBIS vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nebius Group N.V. (NBIS) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NBIS | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.32 | ||
| Sortino ratioReturn per unit of downside risk | +3.56 | ||
| Omega ratioGain probability vs. loss probability | 1.38 | 0.97 | +0.41 |
| Calmar ratioReturn relative to maximum drawdown | 6.96 | -0.42 | +7.38 |
| Martin ratioReturn relative to average drawdown | 15.13 | -0.64 | +15.77 |
Loading charts...
Drawdowns
NBIS vs. NVO - Drawdown Comparison
The maximum NBIS drawdown since its inception was -58.27%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for NBIS and NVO.
Loading charts...
Drawdown Indicators
| NBIS | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.27% | -74.70% | +16.43% |
Max Drawdown (1Y)Largest decline over 1 year | -45.47% | -49.17% | +3.70% |
Max Drawdown (3Y)Largest decline over 3 years | — | -74.70% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -74.70% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -74.70% | — |
Current DrawdownCurrent decline from peak | -24.34% | -64.12% | +39.78% |
Average DrawdownAverage peak-to-trough decline | -18.91% | -17.89% | -1.02% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.88% | 31.80% | -10.92% |
Volatility
NBIS vs. NVO - Volatility Comparison
Nebius Group N.V. (NBIS) has a higher volatility of 37.73% compared to Novo Nordisk A/S (NVO) at 9.44%. This indicates that NBIS's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NBIS | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 37.73% | 9.44% | +28.29% |
Volatility (6M)Calculated over the trailing 6-month period | 77.62% | 36.36% | +41.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 108.22% | 51.69% | +56.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 111.13% | 38.57% | +72.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 111.13% | 32.63% | +78.50% |
Dividends
NBIS vs. NVO - Dividend Comparison
NBIS has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 3.65%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NBIS Nebius Group N.V. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 3.65% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
NBIS vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Nebius Group N.V. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NBIS and NVO have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NBIS has higher volatility (37.73%) compared to NVO (9.44%). In terms of maximum drawdown, NBIS dropped -58.27% vs NVO's -74.70%.
NBIS currently has the higher Sharpe Ratio (2.93 vs -0.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NBIS and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer